全文获取类型
收费全文 | 122篇 |
免费 | 6篇 |
出版年
2022年 | 1篇 |
2021年 | 1篇 |
2020年 | 1篇 |
2018年 | 1篇 |
2017年 | 1篇 |
2016年 | 1篇 |
2015年 | 2篇 |
2014年 | 4篇 |
2013年 | 8篇 |
2012年 | 10篇 |
2011年 | 8篇 |
2010年 | 9篇 |
2009年 | 6篇 |
2008年 | 7篇 |
2007年 | 3篇 |
2006年 | 4篇 |
2005年 | 9篇 |
2004年 | 8篇 |
2003年 | 11篇 |
2002年 | 5篇 |
2001年 | 2篇 |
2000年 | 1篇 |
1999年 | 4篇 |
1998年 | 2篇 |
1997年 | 3篇 |
1996年 | 2篇 |
1995年 | 1篇 |
1994年 | 2篇 |
1993年 | 4篇 |
1991年 | 1篇 |
1990年 | 1篇 |
1988年 | 1篇 |
1985年 | 1篇 |
1983年 | 1篇 |
1981年 | 1篇 |
1973年 | 1篇 |
排序方式: 共有128条查询结果,搜索用时 15 毫秒
41.
Judith H. Waknine-Grinberg Simcha Even-Chen Jasmine Avichzer Keren Turjeman Annael Bentura-Marciano Richard K. Haynes Lola Weiss Nahum Allon Haim Ovadia Jacob Golenser Yechezkel Barenholz 《PloS one》2013,8(8)
Cerebral malaria is the most severe complication of Plasmodium falciparum infection, and a leading cause of death in children under the age of five in malaria-endemic areas. We report high therapeutic efficacy of a novel formulation of liposome-encapsulated water-soluble glucocorticoid prodrugs, and in particular β-methasone hemisuccinate (BMS), for treatment of experimental cerebral malaria (ECM), using the murine P. berghei ANKA model. BMS is a novel derivative of the potent steroid β-methasone, and was specially synthesized to enable remote loading into nano-sterically stabilized liposomes (nSSL), to form nSSL-BMS. The novel nano-drug, composed of nSSL remote loaded with BMS, dramatically improves drug efficacy and abolishes the high toxicity seen upon administration of free BMS. nSSL-BMS reduces ECM rates in a dose-dependent manner and creates a survival time-window, enabling administration of an antiplasmodial drug, such as artemisone. Administration of artemisone after treatment with the nSSL-BMS results in complete cure. Treatment with BMS leads to lower levels of cerebral inflammation, demonstrated by changes in cytokines, chemokines, and cell markers, as well as diminished hemorrhage and edema, correlating with reduced clinical score. Administration of the liposomal formulation results in accumulation of BMS in the brains of sick mice but not of healthy mice. This steroidal nano-drug effectively eliminates the adverse effects of the cerebral syndrome even when the treatment is started at late stages of disease, in which disruption of the blood-brain barrier has occurred and mice show clear signs of neurological impairment. Overall, sequential treatment with nSSL-BMS and artemisone may be an efficacious and well-tolerated therapy for prevention of CM, elimination of parasites, and prevention of long-term cognitive damage. 相似文献
42.
43.
Manaster I Mizrahi S Goldman-Wohl D Sela HY Stern-Ginossar N Lankry D Gruda R Hurwitz A Bdolah Y Haimov-Kochman R Yagel S Mandelboim O 《Journal of immunology (Baltimore, Md. : 1950)》2008,181(3):1869-1876
NK cells populate the human endometrium before pregnancy. Unlike decidual NK cells that populate the decidua during pregnancy, the NK cells present in the human endometrium, before pregnancy, have not been fully characterized. In this study, we provide a detailed analysis of the origin, phenotype, and function of endometrial NK cells (eNK). We show that eNK cells have a unique receptor repertoire. In particular, they are negative for NKp30 and chemokine receptor expression, which distinguishes them from any other NK subset described so far. We further show that eNK cells lack NK-specific functional phenotype and activity such as cytokine secretion and cytotoxicity, before IL-15 stimulation. Following such stimulation, endometrial NK cells acquire phenotype and function that are similar to those of decidual NK cells. We therefore suggest that eNK cells are inactive cells (before IL-15 activation and in relation to the known NK activity) that are present in the endometrium before conception, waiting for pregnancy. 相似文献
44.
Excess beta-catenin promotes accumulation of transcriptionally active p53. 总被引:11,自引:0,他引:11
下载免费PDF全文
![点击此处可从《The EMBO journal》网站下载免费的PDF全文](/ch/ext_images/free.gif)
A Damalas A Ben-Ze''ev I Simcha M Shtutman J F Leal J Zhurinsky B Geiger M Oren 《The EMBO journal》1999,18(11):3054-3063
45.
Simple SummaryERβ, an ER subtype first identified in 1996, is significantly expressed in ERα-negative breast cancer (BCa) and TNBC. Many studies investigated mostly ERβ1 protein expression in the entire cohort of BCa, and the results are inconsistent. In this study, we simultaneously investigated both ERβ mRNA and three ERβ 1, 2, and 5 protein isoforms in various subtypes and subgroups of BCa. Each ERβ isoform’s mRNA and protein expression seemingly plays a significant role in BCa subtypes and subgroups, and ERβ2 mRNA expression is risk factor for poor outcome. Studies in a large cohort of BCa are needed to explore the potential usefulness of ERβ as a prognostic and predictive marker and a therapeutic target in BCa. Furthermore, the standardization of a ERβ testing protocol may be required for ERβ testing to be utilized in a clinical setting.AbstractERβ, an ER subtype first identified in 1996, is highly expressed in different types of BCa including ERα-negative BCa and TNBC. Many studies on ERβ expression investigated mostly on ERβ1 protein expression in ERα-positive and ERα-negative BCa combined. The results are conflicting. This may be due to the complexity of ERβ isoforms, subject heterogeneity, and various study designs targeting different ERβ isoforms and either ERβ protein or mRNA expression, as well as to the lack of a standardized testing protocol. Herein, we simultaneously investigated both mRNA and protein expression of ERβ isoforms 1, 2, and 5 in different BCa subtypes and clinical characteristics. Patient samples (138) and breast cancer cell lines (BCC) reflecting different types of BCa were tested for ERα and ERβ mRNA expression using quantitative real-time PCR, as well as for protein expression of ERα, ERβ1, ERβ2, and ERβ5 isoforms, PR, HER2/neu, Ki-67, CK 5/6, and p53 using immunohistochemistry. Associations of ERβ isoform expression with clinical characteristics and overall survival (OS) were analyzed. ERβ1, 2, and 5 isoforms are differentially expressed in different BCa subtypes including ERα-negative and TNBC. Each ERβ isoform seemingly plays a distinct role and is associated with clinical tumor characteristics and patient outcomes. ERβ isoform expression is significantly associated with >15% Ki-67 positivity and poor prognostic markers, and it predicts poorer OS, mostly in the subgroups. High ERβ2 and 5 isoform expression in ERα-negative BCa and TNBC is predictive of poor OS. Further investigation of ERβ isoforms in a larger cohort of BCa subgroups is needed to evaluate the role of ERβ for the potential usefulness of ERβ as a prognostic and predictive marker and for therapeutic use. The inconsistent outcomes of ERβ isoform mRNA or protein expression in many studies suggest that the standardization of ERβ testing would facilitate the use of ERβ in a clinical setting. 相似文献
46.
47.
Odile Bain Samuel Wanji Gilles Petit Ilan Paperna Simcha Finkelman 《Systematic parasitology》1993,26(2):97-115
Four new species of Splendidofilariinae from different families of lizards are described: Thamugadia wertheimae n. sp., from Acanthodactylus b. boskianus from Israel, Madathamugadia versterae n. sp., from Mabuya capensis from the Northern Transvaal; M. bissani n. sp., from Mabuya quinquetaeniata from Mali; and M. ineichi n. sp., from Pseudocordylus microlepidotus melanotus from the Orange Free State. The life-cycle of M. ineichi is described. It occurs in a Phlebotomus species and is similar to the two known life-cycles in the genus. The new combination Madathamugadia huambensis (Petit, Bain, Gomes & Touratier, 1983) is proposed for the filarial worm from Mabuya aff. quinquetaeniata in Angola, previously placed in the genus Piratuboides (Oswaldofilariinae). Pseudothamugadia physignathi, from Physignathus lesueurii in Australia, is redescribed. In New Guinea, this filarid, or a closely related species, is a parasite of Chlamydosaurus kingii. The presence of splendidofilariines in lizards from southern and western Africa is a new finding. These Ethiopian species show several original characteristics but exhibit affinities with the two Madathamugadia spp. from Malagasy. M. ineichi appears to be a primitive form with a well-developed buccal capsule and well-developed pre- and post-cloacal papillae. Two lines appear to derive from this group: the first is characterised by the reduction of the post-cloacal papillae and comprises the eight species of Madathamugadia in the Ethiopian and Mediterranean regions; the second line is characterised by a reduction of the pre-cloacal papillae and includes the four species of Thamugadia in the Mediterranean region. Morphologically, Pseudothamugadia appears to be closely related to Madathamugadia. 相似文献
48.
49.
50.